DNDStocks's Recent Posts
Title ▼ Rating Company Posted on
Re: Symposium at ESC in Barcelona 1 Resverlogix Corp. Aug 26, 2017 07:46PM
Re: Still waiting for a sufficient answer 7 Resverlogix Corp. May 22, 2018 05:39PM
Re: Still adding..... Resverlogix Corp. Oct 26, 2016 11:32AM
Re: Still adding..... Resverlogix Corp. Oct 26, 2016 12:09PM
Re: Steady as she goes.... 3 Resverlogix Corp. Sep 24, 2015 12:14PM
Re: Speculation on a US listing put to rest? 3 Resverlogix Corp. Jun 04, 2019 08:45PM
Re: Some final thoughts on analysts in general and Zacks in particular..... 6 Resverlogix Corp. Nov 04, 2015 08:26AM
Re: So, how long do we have now?... 3 Resverlogix Corp. Jun 09, 2017 03:47PM
Re: Slide 27 - I would get rid of it.... Resverlogix Corp. Sep 17, 2016 09:35PM
Re: Share offering a win/win for shareholders? 2 Resverlogix Corp. May 24, 2019 10:46AM
Re: Seeming lack of interest 4 Resverlogix Corp. Sep 11, 2019 10:09PM
Re: Sedar filings - Loan balance 4 Resverlogix Corp. Jul 30, 2019 07:10PM
Re: RVX announces...THIS IS FROM RVX 6 Resverlogix Corp. Oct 13, 2017 10:03AM
Re: RVX announces...THIS IS FROM RVX 5 Resverlogix Corp. Oct 13, 2017 10:20AM
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments 3 Resverlogix Corp. Dec 18, 2017 09:01AM
Re: RVX + FDA news - thoughts 2 Resverlogix Corp. Feb 03, 2020 01:05PM
Re: RVX & Esperion 3 Resverlogix Corp. Mar 21, 2017 10:52AM
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits 4 Resverlogix Corp. Jul 08, 2019 01:07PM
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits 3 Resverlogix Corp. Jul 08, 2019 02:40PM
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone 1 Resverlogix Corp. May 30, 2017 02:37PM